The Amplify CWP Growth & Income ETF (QDVO) provides a high 10.56% trailing yield through a concentrated portfolio of large-cap growth stocks combined with tactical covered call strategies. It stands out for its relatively low volatility and active management approach. However, its recent performance has lagged behind key growth-income peers such as JEPQ and QQQI. The analyst rates QDVO as a HOLD, preferring to wait for sustained outperformance before recommending it, noting that while current market conditions might favor QDVO’s strategy, there are stronger alternatives for investors prioritizing income, cost efficiency, or total return.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...
Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...
Vault Strategic Mining Corp has updated the terms of its non-brokered private placement, now offering up to 12 million units at $0.125 each, aiming to raise $1.5 million. Each unit includes one common share and one warrant exercisable at $0.20 within...
Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...
